BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38440796)

  • 1. Use of Magnetic Resonance Imaging for Visualization of Oral Dosage Forms in the Human Stomach: A Scoping Review.
    Akbar T; Gershkovich P; Stamatopoulos K; Gowland PA; Stolnik S; Butler J; Marciani L
    Mol Pharm; 2024 Apr; 21(4):1553-1562. PubMed ID: 38440796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous in vivo visualization and localization of solid oral dosage forms in the rat gastrointestinal tract by magnetic resonance imaging (MRI).
    Christmann V; Rosenberg J; Seega J; Lehr CM
    Pharm Res; 1997 Aug; 14(8):1066-72. PubMed ID: 9279890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic Resonance Imaging to Visualize Disintegration of Oral Formulations.
    Curley L; Hinton J; Marjoribanks C; Mirjalili A; Kennedy J; Svirskis D
    J Pharm Sci; 2017 Mar; 106(3):745-750. PubMed ID: 27964901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of disintegration rate is important for predicting the oral absorption of solid dosage forms containing poorly soluble weak base drugs.
    Nakamura K; Kambayashi A; Onoue S
    Eur J Pharm Biopharm; 2022 Nov; 180():23-32. PubMed ID: 36154905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract.
    Weitschies W; Blume H; Mönnikes H
    Eur J Pharm Biopharm; 2010 Jan; 74(1):93-101. PubMed ID: 19619649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic images of the disintegration process of tablets in the human stomach by ac biosusceptometry.
    Corá LA; Andreis U; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Miranda JR
    Phys Med Biol; 2005 Dec; 50(23):5523-34. PubMed ID: 16306649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Application of MRI and the Salivary Tracer Technique to Determine the in Vivo Disintegration Time of Immediate Release Formulation Administered to Healthy, Fasted Subjects.
    Sager M; Grimm M; Jedamzik P; Merdivan S; Kromrey ML; Hasan M; Koziolek M; Tzvetkov MV; Weitschies W
    Mol Pharm; 2019 Apr; 16(4):1782-1786. PubMed ID: 30821987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated system for dissolution studies and magnetic resonance imaging of controlled release, polymer-based dosage forms-a tool for quantitative assessment of hydrogel formation processes.
    Kulinowski P; Dorozyński P; Jachowicz R; Weglarz WP
    J Pharm Biomed Anal; 2008 Nov; 48(3):685-93. PubMed ID: 18715732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simulating the postprandial stomach: physiological considerations for dissolution and release testing.
    Koziolek M; Garbacz G; Neumann M; Weitschies W
    Mol Pharm; 2013 May; 10(5):1610-22. PubMed ID: 23506381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.
    Koziolek M; Görke K; Neumann M; Garbacz G; Weitschies W
    Eur J Pharm Sci; 2014 Jun; 57():250-6. PubMed ID: 24051217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disintegration of magnetic tablets in human stomach evaluated by alternate current biosusceptometry.
    Corá LA; Américo MF; Oliveira RB; Baffa O; Moraes R; Romeiro FG; Miranda JR
    Eur J Pharm Biopharm; 2003 Nov; 56(3):413-20. PubMed ID: 14602185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the in vivo disintegration of solid dosage forms of a bile acid sequestrant in dogs using gamma-scintigraphy and correlation to in vitro disintegration.
    Hussain MA; Chang RK; Sandefer E; Page RC; Digenis GA
    Pharm Res; 2003 Mar; 20(3):460-4. PubMed ID: 12669969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic Resonance Imaging Quantification of Fasted State Colonic Liquid Pockets in Healthy Humans.
    Murray K; Hoad CL; Mudie DM; Wright J; Heissam K; Abrehart N; Pritchard SE; Al Atwah S; Gowland PA; Garnett MC; Amidon GE; Spiller RC; Amidon GL; Marciani L
    Mol Pharm; 2017 Aug; 14(8):2629-2638. PubMed ID: 28648070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biorelevant in-vitro performance testing of orally administered dosage forms.
    Reppas C; Vertzoni M
    J Pharm Pharmacol; 2012 Jul; 64(7):919-30. PubMed ID: 22686340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release and bioaccessibility of oral solid preparations in a dynamic gastrointestinal system simulating fasted and fed states: A case study of metformin hydrochloride tablets.
    Yang S; Hu Z; Wu P; Kirk T; Chen XD
    Int J Pharm; 2024 Mar; 652():123869. PubMed ID: 38296171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo characterization of enTRinsic™ drug delivery technology capsule after intake in fed state: A cross-validation approach using salivary tracer technique in comparison to MRI.
    Sager M; Grimm M; Aude P; Schick P; Merdivan S; Hasan M; Kromrey ML; Sivert A; Benameur H; Koziolek M; Tzvetkov MV; Weitschies W
    J Control Release; 2019 Nov; 313():24-32. PubMed ID: 31626859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy.
    Kelly K; O'Mahony B; Lindsay B; Jones T; Grattan TJ; Rostami-Hodjegan A; Stevens HN; Wilson CG
    Pharm Res; 2003 Oct; 20(10):1668-73. PubMed ID: 14620524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations.
    Schick P; Sager M; Voelker M; Weitschies W; Koziolek M
    Eur J Pharm Biopharm; 2020 Jun; 151():9-17. PubMed ID: 32268191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic investigation of food effect on disintegration and dissolution of BCS class III compound solid formulations: the importance of viscosity.
    Radwan A; Amidon GL; Langguth P
    Biopharm Drug Dispos; 2012 Oct; 33(7):403-16. PubMed ID: 22782559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.